LTFU Study of Subjects Who Received GRNOPC1
About this trial
This is a LTFU study for thoracic SCI subjects that were administered GRNOPC1 cells in the main study CP35A007....
Included participants
What’s involved
Type
Details
Study CP35A008 is a Phase 1, multi-center long term follow-up (LTFU) study for five (5) subjects with complete thoracic SCI that were administered 2 million GRNOPC1 cells in the main study CP35A007. The purpose of this study is to monitor long-term safety in subjects for 15 years post GRNOPC1 administration.
Potential benefits
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more- Trial recruitment status
- Active
- Trial start date
- 6 Oct 2011
- Organisation
- Lineage Cell Therapeutics, Inc.
- Trial recruitment status
- Active
- Trial start date
- 6 Oct 2011
- Organisation
- Lineage Cell Therapeutics, Inc.
About this trial
Included participants
What’s involved
Potential benefits
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more